Coronation Fund Managers Ltd. Danaher Corp Transaction History

Coronation Fund Managers Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$235.51 - $267.98 $346,199 - $393,930	1,470 Added 29.88%	6,389 $1.6 Million
Q1 2024 May 03, 2024	SELL	$224.58 - $256.19 $11.7 Million - $13.3 Million	-51,947 Reduced 91.35%	4,919 $1.23 Million
Q4 2023 Feb 09, 2024	SELL	$185.1 - $233.13 $11,291 - $14,220	-61 Reduced 0.11%	56,866 $13.2 Million
Q3 2023 Oct 18, 2023	BUY	$233.08 - $265.59 $8.96 Million - $10.2 Million	38,433 Added 207.81%	56,927 $14.1 Million
Q2 2023 Jul 27, 2023	BUY	$224.99 - $256.14 $1.6 Million - $1.83 Million	7,131 Added 62.76%	18,494 $4.44 Million
Q1 2023 May 05, 2023	SELL	$239.75 - $277.0 $725,963 - $838,756	-3,028 Reduced 21.04%	11,363 $2.86 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $3.47 Million - $4.06 Million	14,391 New	14,391 $3.82 Million

2,525

550M

7.1M

5.14M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.